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Temporal lobe epilepsyThere is evidence that some types of epilepsy progress over time, and an important part of this knowledge
has derived from neuroimaging studies. Different authors have demonstrated structural damage more pro-
nounced in individuals with a longer duration of epilepsy, and others have been able to quantify this progres-
sion over time. However, others have failed to demonstrate progression possibly due to the heterogeneity of
individuals evaluated. Currently, temporal lobe epilepsy associated with hippocampal sclerosis is regarded as
a progressive disorder. Conversely, for other types of epilepsy, the evidence is not so clear. The causes of this
damage progression are also unknown although there is consistent evidence that seizure is one of the mech-
anisms. The conﬂicting data about epilepsy progression can be a challenge for clinical decisions for an indi-
vidual patient. Studies with homogenous groups and longer follow-up are necessary for appropriate
conclusions about the real burden of damage progression in epilepsies, and neuroimaging will be essential
in this context.
This article is part of a Special Issue entitled “The Future of Translational Epilepsy Research”.
© 2012 Elsevier Inc.Open access under the Elsevier OA license.1. Current evidence of epilepsy progression
“Seizures beget seizures” has been a famous citation by William
Gowers [1] for more than 100 years. It brings the implicit concept
that epilepsy may be a progressive disorder and, more speciﬁcally, re-
lated to the occurrence of seizures. However, as clinical neurologists,
how does it affect (or how should it affect) our decisions facing a spe-
ciﬁc patient with epilepsy?
Epilepsy progression can be veriﬁed or described as the worsening
of seizure control, cognition, behavior, structural abnormalities, and
EEG patterns as well as social interactions over time. Overall, it is
not possible to say that all types of epilepsy are progressive condi-
tions [2,3]. While some epilepsy syndromes are clearly progressive,
others do not appear to progress over time, and yet it is unclear if in
some localization-related epilepsies, the progression of damage de-
pends on the underlying etiology, seizure type (i.e., presence or not
of secondary generalized seizures), duration and frequency of sei-
zures, other environmental factors (e.g., viral infections and head
trauma), or a combination of several of these factors. For example,
prolonged focal seizures, prolonged generalized seizures, isolated ormparo à Pesquisa do Estado de
-9.
iversity of Campinas, UNICAMP,
inas, SP, CEP 13083-970, Brazil.
ier OA license.clusters of brief seizures, or seizures with a longer seizure-free inter-
val may have distinct effects on brain integrity.
The controversy begins in studies about the natural history of epi-
lepsies. Some of these showworse prognosis of seizure control associ-
ated with the number of seizures prior to treatment and a tendency to
progressive reduction of seizure-free intervals in populations without
treatment [4–7]. However, other authors disagree with these results
emphasizing that this tendency of worsening over timemay be related
to an inherent severity of the disease in these individuals [8,9]. Similar-
ly, community-based studies of patientswith several years of delay be-
fore starting antiepileptic drug (AED) therapy show similar patterns of
response than studies with newly diagnosed epilepsies [10,11].
Studies conducted in tertiary centers with patients with drug-
refractory seizures have diverse results. In this context, experimental,
neuroimaging, EEG, and clinical studies have consistently pointed
towards a tendency of progression among the years in some types of ep-
ilepsy, especially drug-refractory temporal lobe epilepsy (TLE) associat-
ed with hippocampal sclerosis (HS) (TLE–HS), which can be identiﬁed
in vivo by MRI (Fig. 1) [12–15]. Studies of TLE have shown clinical [7],
cognitive [16,17], electroencephalographic [18,19], and neuroimaging
evidence of progressive damage [12–15]. However, lack of evidence ex-
ists in other types of focal or generalized epilepsies. Moreover, the
knowledge of what contributes to this progression, even in TLE, is not
well understood.
Some studies show an important role of seizures in this progressive
damage [14,15] while others do not [20]. For example, some experi-
mental data suggest that the recurrence of seizures may be responsible
Fig. 1. 3-Tesla MRI coronal T1-weighted inversion recovery (A1 and A2) and T2-FLAIR (ﬂuid-attenuated inversion recovery) images (B1 and B2) from a patient with left mesial TLE
showing signs of left hippocampal sclerosis (arrows): hippocampal atrophy with abnormal shape and hyperintense signal on T2-FLAIR images.
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evidence in patients with epilepsy correlates the occurrence of
drug-refractory seizures with lower hippocampal neuronal density
[22]. Conversely, a post-mortem study showed that not all patients
with drug-refractory seizures have signiﬁcant hippocampal neuronal
loss [23].
Recently, important data about the role of uncontrolled inﬂamma-
tion in the progress of epilepsy damage have emerged [24]. In vitro
and in vivo data support the idea that inﬂammation may play a role in
the epileptogenic process. In addition, it is possible that uncontrolled in-
ﬂammation may be implicated in the chronic epileptic process of TLE–
HS [24,25], thus, adding additional neuronal damage over years.
In this review, we will focus on neuroimaging evidence of progres-
sive damage in epilepsy. Although the gold standard for brain damage
related to progression of epilepsy is the pathological examination,
MRI – especially the newer scans with larger ﬁelds of 3 T to 7 T –
can provide an in vivo analysis that can approach what is seen in his-
topathology. We will focus on focal symptomatic/cryptogenic and id-
iopathic generalized epilepsies, while clearly progressive disorders
(e.g., progressive myoclonic epilepsies or West syndrome) will not
be discussed. We will speciﬁcally try to emphasize the evidence that
is already relevant for clinical practice. Moreover, we will try to
point out the gaps and the perspectives and look ahead to the knowl-
edge that is likely to emerge in the next years and what relevance it
may have in our daily actions as clinical neurologists. Special atten-
tion will be given to the important role that neuroimaging techniques
may play in ﬁlling these gaps.2. Neuroimaging evidence of epilepsy progression
Magnetic resonance imaging is the most important neuroimaging
tool for the evaluation of epilepsies. It can image the structural sub-
strate responsible for the epileptic process [26] and reveal signs of
HS, malformations of cortical development, tumors, or other underly-
ing conditions. It is particularly sensitive for detecting signs of HSin TLE patients, which can be seen as a reduction of volume, loss of
hippocampal internal structure, and increased hippocampal T2 signal
[27,28]. In the last two decades, with the emergence of more sophis-
ticated scans and quantitative analysis, the literature about progres-
sive epilepsy damage and MRI techniques has grown. For other
neuroimaging techniques, such as PET or SPECT, the literature regard-
ing the progressive damage of epilepsies is not so vast.2.1. Cross-sectional neuroimaging evidence of epilepsy progression
2.1.1. MRI manual and automatic volume measures
Manual volumetry has been repeatedly used to evaluate structural
progression in epilepsy (Fig. 2). In the early 1990s, an MRI volumetric
study composed predominantly of patients with drug-refractory TLE
(but which also included extra-temporal epilepsies) did not observe a
relation of repeated seizures or longer duration of epilepsy with the de-
gree of atrophy of the amygdala and hippocampus [29]. Conversely,
more homogeneous studies including only individuals with TLE demon-
strated that hippocampal [30,31] and amygdala [31] volumes were neg-
atively correlated with the duration of epilepsy. Although themajority of
published papers include TLE–HS patients, a study with cryptogenic TLE
[14] also demonstrated that those with the epileptic focus in the left hip-
pocampus had the ipsilateral hippocampal volume inversely correlated
with the estimated total number of partial or generalized seizures.
Manual and automatic volumetric and signal quantiﬁcation tech-
niques have helped to determine that the structural damage of epi-
lepsies extends beyond the epileptic focus, and authors have also
tried to correlate this diffuse damage with the occurrence of seizures
or duration of the disease. Semi-automated volumetric study of uni-
lateral TLE patients demonstrated that duration of epilepsy was asso-
ciated with reduced ipsilateral hippocampal volume and bilateral
extra-temporal (frontal and parietal) white matter volume [32]. Sim-
ilarly, childhood onset (but not adult onset) TLE has been associated
with signiﬁcantly reduced total brain tissue [33]. Another study,
with reﬁned cortical analysis, demonstrated that neocortical atrophy
Fig. 2.Manual volumetry of hippocampi of two patients with temporal lobe epilepsy. Image A shows the quantiﬁcation of volume in a patient with visually detected left hippocampal
atrophy. Image B shows reduction of volume in the right hippocampus, which was not detected by visual analysis. The quantiﬁcation of hippocampal and other brain structure
volumes can help to evaluate progression of structural damage in patients with epilepsy.
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correlated with longer epilepsy duration [34]. However, other studies
have failed to demonstrate that structural damage outside the pre-
sumed epileptogenic zone can be progressive. For example, Moran
et al. [35] found signiﬁcant atrophy of mesial and lateral temporal
lobe substructures, but there was no correlation between the degree
of atrophy in the extra-hippocampal temporal lobe structures and
the duration of epilepsy or occurrence of generalized seizures.
Other automatic MRI quantitative analyses, such as voxel-based
morphometry (VBM), also helped to address the question of brain
damage progression. Voxel-based morphometry is a technique that
allows the MRI evaluation of gray and white matter concentrations
or volumes through an automatic analysis of the whole brain [36]. A
VBM analysis of unilateral TLE patients showed that only extra-
temporal (bilateral thalamic, prefrontal, and cerebellar) but not mesi-
al temporal gray matter concentration was related to duration or age
of onset of epilepsy [37]. Similarly, another VBM study [38] demon-
strated that gray matter concentration in the ipsilateral hippocampus,
temporal lobes, and extra-temporal limbic structures in patients with
MTLE is negatively correlated with the duration of epilepsy.
The data about epilepsy progression for other focal or idiopathic gen-
eralized epilepsies (IGE) are scarce. In IGE, while some studies have
failed to demonstrate thalamic atrophy in small groups of patients
[39–41], a more recent study [42] including a larger number of IGE indi-
viduals who presented only generalized tonic-clonic seizures demon-
strated bilateral thalamic atrophy. Moreover, the authors observed that
the thalamic volumes and the fronto-central and limbic cortices were
negatively correlated with duration of epilepsy, and this progression oc-
curred even faster in patients with poorer seizure control. These results
emphasize the concept that different factors may inﬂuence structural
progressive damage in individuals with epilepsies, and the homogeneity
of the patients included in the analysis may contribute to a better under-
standing of these issues.2.1.2. Other neuroimaging techniques
2.1.2.1. MRI T2 relaxometry.Magnetic resonance imaging T2 relaxome-
try is a technique that allows the quantiﬁcation of signal intensity in
MRI scans (Fig. 3) and can help to improve the detection of structural
brain pathologies such as HS [43]. There are contradictory data about
T2 relaxometry and epilepsy progression. Kalviainen et al. [14] dem-
onstrated that patients with cryptogenic TLE and the epileptic focus
in the left hippocampus had a T2 relaxation time that positively
correlated with the estimated total number of partial or generalized
seizures. Conversely, Grünewald et al. [44] could not observe any cor-
relation of hippocampal T2 relaxation times with seizure frequency or
duration of epilepsy in individuals with partial epilepsy.
In a group of 43 patients with drug-refractory TLE and MRI signs of
HS, we did not ﬁnd a signiﬁcant relationship between frequency and
the duration of seizures and hippocampal T2 relaxometry (unpublished
data).
2.1.2.2. MRI spectroscopy. Magnetic resonance imaging spectroscopy
allows the observation of cerebral metabolites, and studies in epilep-
sy have shown that it can help to demonstrate neuronal damage that
correlates with clinical–electroencephalographic lateralization in TLE
[45]. Some cross-sectional studies using MRI spectroscopy have dem-
onstrated correlation of seizure frequency [46] and epilepsy duration
[30] with a reduction in the N-acetylaspartate-to-creatine ratio (NAA/
Cr) in patients with medically intractable TLE. Conversely, other stud-
ies have failed to demonstrate this correlation [47].
2.1.2.3. PET. Positron emission tomography provides images of differ-
ent biochemical functions in the human brain, and abnormal glucose
metabolism has been associated with the epileptic focus [26]. Gaillard
et al. [48] demonstrated that abnormalities of glucose utilization seen
in [18F]-ﬂuorodeoxyglucose (18FDG)-PET are less common in children
Fig. 3. Screenshot from the program Aftervoxel (http://www.liv.ic.unicamp.br/~bergo/aftervoxel) used to measure T2 signal (relaxometry), showing a coronal T2-weighted image
with regions of interest (ROIs) painted on each hippocampus. A T2 map is obtained from a T2 multi-echo sequence (in this case, six echoes). The program calculates the signal in-
tensity of the ROIs that are chosen by the operator: in this example one ROI is placed in the left (red) and another in the right (yellow) hippocampus. It is also possible to obtain
several ROIs in the same structure (for example, ROIs along the hippocampus) and calculate the average signal from ROIs in each structure. Different from hippocampal volumetry,
the ROIs here do not need to cover the entire structure, and its shape is not important because we are obtaining an average of signal intensity. It is important, however, to avoid
contamination of surrounding tissues.
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epilepsy. Similar results have been found by Theodore et al. [49],
who demonstrated with PET exams that longer duration of epilepsy
in TLE is associated with greater hypometabolism in the hippocampus
ipsilateral to the epileptic focus.
2.2. Longitudinal neuroimaging evidence of epilepsy progression
To evaluate the evolution of a disease, longitudinal studies are
more appropriate than cross-sectional analysis, and extensive data
with neuroimaging follow-up have been published in the last decades.
However, most of the studies have a short follow-up period, usually
less than 5 years.
2.2.1. MRI manual and automatic volume measures
Longitudinal studies including community-based or newly diag-
nosed epilepsies (which are invariably composed of highly hetero-
geneous individuals) show that epilepsy, as a single group, is not
consistently a progressive disorder. For example, Van Paesschen et al.
[50] evaluated patients with newly diagnosed partial epilepsy with
MRI scans at a one-year interval and demonstrated subtle changes in
only three individuals. Similarly, a study that followed adult patients
with newly diagnosed seizures with two MRIs 3.5 years apart showed
that quantitative analysis of the hippocampus, cerebellum, and
total brain volume did not differ between patients and controls or
patients with or without further seizures [2]. Recently, the same
group [51] found a signiﬁcant difference in neocortical volume loss
between controls and patients with chronic epilepsies in MRIs
3.5 years apart but not between controls and newly diagnosed epi-
lepsies. However, this increased risk of cerebral atrophy was not re-
lated to a history of seizures.
In more homogenous groups including only TLE patients, usually
associated with HS, the results of longitudinal quantitative MRI anal-
yses with manual or automated techniques point towards a slow butconsistent structural progression. This progression is seen not only in
the mesial temporal region but also in extra-temporal areas from the
early phases of the disease. For example, Briellmann et al. [12] showed
in a group of newly diagnosed TLE patients an ipsilateral hippocampal
volume decrease of 9% over a mean period of 3.5 years. They also ver-
iﬁed that the hippocampal volume loss was correlated to the number
of generalized seizures between the scans. A comparable result was
demonstrated by Fuerst et al. [13]. In this study, in which patients
with TLE and unilateral hippocampal sclerosis had repeat volumetric
magnetic resonance imaging scans with a mean of 3.4-year interval,
seizure-free patients showed no change in hippocampal volume,
while those with continuing seizures had a decline in ipsilateral hip-
pocampal volume that correlated with seizure frequency.
Results of longitudinal studies were similar to cross-sectional analy-
sis regarding progressive abnormalities distant from the epileptic focus.
In the study from Liu et al. [51], the ongoing cerebral atrophy observed
waswidespread and remote from the epileptic focus. Also, Bernhardt et
al. [34] evaluated neocortical atrophy in TLE in a longitudinal analysis
with a mean of 2.5 years of follow-up and detected progression of cor-
tical atrophy in the ipsilateral temporopolar and central areas, and con-
tralateral orbitofrontal, insular, and angular regions. In a VBM analysis
of TLE patients performed in our center [15], we observed progressive
gray and white matter reduction not only in the ipsilateral mesial tem-
poral region but also in the ipsi- and contra-lateral neocortical areas of
temporal, frontal, and occipital regions. This progressive damage was
associatedwith poorer seizure control and a longer duration of epilepsy.2.2.2. Other neuroimaging techniques
2.2.2.1. MRI T2 relaxometry. A study with patients with chronic focal
and generalized epilepsies failed to demonstrate quantitative changes
of hippocampal T2 relaxation times after a follow-up period of 115–
331 days [44].
Fig. 4. In a group of 84 patients with benign focal epilepsies, those with hippocampal
atrophy detected by manual volumetry had signiﬁcantly longer epilepsy duration
than those with normal hippocampal volume (two-sample T-test, p=0.003). HV: hip-
pocampal volume and HA: hippocampal atrophy.
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cortical glucose hypometabolism in children with intractable non-
lesional partial epilepsy, and these changes were related to the fre-
quency of seizures [52].
2.3. The role of seizures and other clinical evidence of
epilepsy progression
In humans, there are numerous descriptions of status epilepticus
(SE) leading to neuronal changes, especially in the hippocampus
[53,54]. There is extensive MRI evidence that febrile and afebrile SE
can damage the brain and that the mesial structures are especially
vulnerable to the hypoxia that occurs in association with status
epilepticus [55]. In contrast, for brief recurrent seizures, the relation
with brain damage is not so clear. Despite the evidence of progressive
structural damage in some types of epilepsy, the causative relation of
this with sporadic or refractory seizures is still controversial [56].
A few case reports have described clear progressive hippocampal
damage that could be secondary to brief and sporadic generalized or
focal seizures. O'Brien et al. [57] reported a case of long-standing in-
tractable complex partial and secondary generalized seizures whose
MRI scans 4 years apart documented a progressive decrease in the
left hippocampal volume. Briellman et al. [58] described a patient
who developed reduced hippocampal volume and increased hippo-
campal T2 signal after six generalized tonic-clonic seizures (GTCS).
Worrell et al. [59] described MRI signs of hippocampal atrophy that
developed in an adult after the occurrence of new-onset partial sei-
zures and only one brief GTCS from acute venous thrombosis.
One major problem of determining whether seizures cause pro-
gressive damage is that almost invariably, the researchers can rely
only on patients' and observers' reports. In this context, the number
or type of seizures presented in a deﬁned interval is not always pre-
cise since the majority of patients with epilepsy have unnoticed sei-
zures [60]. So, any study addressing the number of seizures will
report only a proportion of possible seizures that occurred in that pe-
riod. In addition, different types of seizures have probably different
weights in the progression of epilepsies. Moreover, different types
of seizures may involve different patterns of neural networks in dif-
ferent individuals, and it may also inﬂuence the structural abnormal-
ities observed in each patient. According to the evidence that we have
so far, we may infer that some types of seizures in some speciﬁc epi-
lepsies and in individuals with some distinct characteristics may lead
to progressive structural damage and cognitive dysfunction.
Another difﬁculty is to differentiate if the association of more ex-
tensive structural damage and higher seizure frequency is due to
the consequence of recurrent seizures per se or to the vulnerability
that patients with more aggressive disease have from the beginning
of their refractory seizures.
Some cross-sectional and longitudinal MRI studies support the hy-
pothesis that seizures may inﬂuence structural damage. Bilevicius
et al. [61] demonstrated in a quantitative MRI cross-sectional analysis
more pronounced and widespread gray matter abnormalities in
AED-resistant and relapse-remitting TLE individuals when compared
with AED responders. A longitudinal VBM analysis in patients with
TLE [15] also demonstrated progressive mesial temporal and neo-
cortical damage associated with poorer seizure control. Also, a study
including patients with IGE with only tonic-clonic seizures [42] ob-
served that the reduction of thalamic volumes and fronto-central
and limbic cortices occurred faster in patients with poorer seizure
control.
Other studies support the hypothesis that GTCS and not partial
seizures may be causative of damage [30,62].
Conversely, some studies contradict the theory that seizures cause
further injury in individuals with epilepsy [2,29,51]. However, the
majority of these are composed of community-based or very hetero-
geneous groups of individuals.Besides the heterogeneity of the individuals included in the
community-based studies, according to epidemiological data, up to
70% of patients with epilepsy will have adequate seizure control
with AED therapy [3]. Hence, the question arises if the study of more
homogenous groups of patients with well-controlled seizures could
demonstrate progression even in some patients with more “benign”
epilepsy. Andrade-Valenca et al. [63] showed in an MRI volumetric
analysis that TLE–HS, half of which with good seizure control, failed
to demonstrate any correlation of seizures with the degree of hippo-
campal atrophy. Recently, a cross-sectional quantitative MRI study
[64] showed cortical thinning, mainly in the sensoriomotor cortex in
individuals with “benign” TLE patients with or without MRI signs of
HS. All patients had been free of major seizures for at least 1 year be-
fore theMRI, which supports the idea that the pathology in neocortical
regions may be implicated in pathophysiology of TLE. Our group also
showed [65], in an extensive follow-up with a medium of 90 months,
progressive hippocampal volume reduction in a group of familial me-
sial TLE (FMTLE) in which 71% of the individuals were classiﬁed as be-
nign. In this study – compared with a group of individuals with
sporadic MTLE, in which only 12% were considered benign – FMTLE
had a slower progression of hippocampal volume reduction. This evi-
dence supports the hypothesis that although seizures may contribute
to additional injury in some types of epilepsy, a slower progressive
damage may be intrinsic to the pathophysiology of MTLE.
The duration of epilepsy, independent of the occurrence or fre-
quency of seizures, has also been addressed as involved in the process
of epilepsy progression, affecting regions in the epileptic focus [66,67],
aswell as distant areas as thalamus [67] and neocortical structures [15]
(Fig. 4). Similarly, the age of epilepsy onset has also been described as
related toworsening of structural damage in TLE [67,68], and some au-
thors have proposed that childhood onset epilepsy may be associated
with an adverse neurodevelopmental impact on brain structure and
function [68]. However, other studies failed to support this evidence
[66].
Some more speciﬁc individual characteristics have been related to
progressiveMRI structural damage in epilepsies. In one studywith TLE
patients [14], only individuals with an epileptic focus on the left side
had a hippocampal volume and signal that correlatedwith the number
of partial or generalized seizures, while in another study [15], gray and
white matter diffuse progressive abnormalities were more pro-
nounced in individuals with a left-sided EEG focus (Fig. 5). Briellmann
et al. [69] proposed that seizure frequency may be a factor contribut-
ing to reduced brain volume in men but not in women with TLE. In a
VBM study of individuals with drug-refractory TLE, Yasuda et al. [70]
Fig. 5. Longitudinal analysis of GM volumes in MRI scans of patients with TLE–HS (13 with right HS and nine with left HS) and refractory seizures. The images where acquired at a
mean interval of 16 months (range 6–29 months), with no signiﬁcant difference in the follow-up interval between patients with right or left HS (T-test=0.30). A: areas of progres-
sive GM reduction in patients with right TLE–HS compared with left TLE–HS; B: areas of progressive GM reduction in patients with left TLE–HS compared with right TLE–HS (VBM
analysis: vbm8 toolbox, longitudinal analysis; two-sample T-test, p=0.001, FDR corrected). The glass brain images on the right columns of Panels A and B clearly show that patients
with left HS havemore pronounced GM progressive reduction (B) than those with right HS. GM: graymatter; TLE–HS: temporal lobe epilepsy associated with hippocampal sclerosis;
VBM: voxel-based morphometry; and FDR: false discovery rate.
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more widespread pattern of gray matter abnormalities as well as
lower IQ scores than those with a positive family history, suggesting
that in the ﬁrst group, a stronger environmental inﬂuence may be re-
lated to the more intense clinical and structural abnormalities.
The inﬂuence of AED exposure in epilepsy progression is also not
well understood. One study [51] has observed generalized brain atro-
phymore commonly in patientswith increased exposure to AEDs, inde-
pendently of seizure control. However, no large available datasets have
been published, and the difﬁculties of this type of evaluation are vast.The majority of individuals with refractory epilepsies, which according
to the data available are the ones more vulnerable to epilepsy progres-
sion, are exposed to AED polytherapy with frequent modiﬁcation of
dosages and types of AEDs.
2.4. The contribution and perspectives of new neuroimaging techniques
In the last decade, an extensive number of reﬁned quantitative MRI
post-processing tools have emerged. While for some tools the techni-
cal issues still need to be solved, others have already given us new
319A.C. Coan, F. Cendes / Epilepsy & Behavior 26 (2013) 313–321important clues about the pathophysiology of epilepsies. However, the
use of these techniques to answer the questions about epilepsy progres-
sion is still scarce.
2.4.1. Diffusion tensor imaging/tractography
Diffusion tensor imaging (DTI) can study the white matter integri-
ty through the evaluation of water diffusion [71]. Diffusion tensor
imaging abnormalities have been described in malformations of cor-
tical development and idiopathic generalized epilepsies [72,73], but
the majority of studies have focused so far on TLE. White matter
abnormalities in cross-sectional DTI studies of TLE patients were
observed in bilateral temporal regions [74] as well as in bilateral
extra-temporal areas belonging to the limbic system [75].
It is possible that these white matter abnormalities may be sec-
ondary to seizure activity [64]. However, the correlation of these ab-
normalities with seizures and epilepsy duration has not yet been
adequately evaluated and long-term follow-up studies are still neces-
sary. Some DTI studies with TLE patients found a correlation between
abnormalities in white matter and duration of epilepsy, especially in
patients with HS [76,77]. However, this has been contradicted by
other studies [74,78].
More recently, in one study with DTI, Kim et al. [79] also demon-
stratedwidespread disturbance ofwhitematter integrity in the frontal
lobe and corpus callosum of patients with juvenile myoclonic epilep-
sy, and the number of GTCS was correlated with these abnormalities.
2.4.2. Functional MRI (fMRI)
Functional magnetic resonance imaging allows the measurement
of brain activity by detecting signal changes associated with changes
in blood ﬂow and changes in blood oxygenation [80]. It has been
used as an important clinical tool for evaluation of memory perfor-
mance [81,82] and to map eloquent areas for surgical planning [83].
This capacity of a non-invasive evaluation of hemodynamic changes
associated with neural activity allows the possibility of evaluating
different aspects related to the epilepsy progression. For example,
Cheung et al. [84] demonstrated that the longer the duration of epilep-
sy, the lower the brain activation in a visual scene-encoding task with
TLE patients and that this reduction of brain activation negatively af-
fects memory function. However, the available fMRI data concerning
progressive damage are still scarce.
Other promising results regarding the epilepsy process and pro-
gression may come from fMRI studies of resting state and default
mode network (DMN) (which appears to include areas involved in
the maintenance of baseline activities related to the modulation dur-
ing internal and external tasks, self-awareness, and episodic memory)
[85,86]. Pieces of evidence suggest that the DMN is abnormal in pa-
tients with TLE [87,88] and IGE [89] and that the inter-ictal epilepti-
form discharge may be implicated in the deactivation of the DMN in
IGE [90], TLE [91,92], and other types of focal epilepsies [92]. Func-
tional magnetic resonance imaging studies also demonstrated abnor-
mal functional connectivity in DMN areas in TLE [93,94]. Extensive
work is necessary to understand if these abnormalities in the DMN
and speciﬁc connectivity patterns have any relation to the occurrence
of seizures or duration of epilepsy and if it can be part of the progres-
sion of some types of epilepsy.
Multimodal neuroimaging techniques, such as the use of con-
comitant EEG and fMRI (EEG–fMRI), may be able in the future to
add more knowledge through a reﬁned non-invasive evaluation.
Electroencephalography–functional magnetic resonance imaging has
been proven to help in the identiﬁcation of the epileptogenic focus in
focal refractory epilepsies [95–98] as well as to evaluate networks
involved in different types of epilepsies [90–92]. This technique may
be able to provide signatures that could enable the classiﬁcation of
more homogeneous groups, and it could also help to evaluate differ-
ences and long-term modiﬁcations of networks implicated in ictal and
inter-ictal abnormalities in different groups of patients with epilepsy.2.4.3. Other promising neuroimaging techniques
Other promising MRI techniques that may contribute to the study
of epilepsy progression have also emerged in the last two decades.
Higher ﬁeld (3 T) MRIs have allowed the improvement of some tech-
niques, such as spectroscopy [99] and arterial spin label [100,101]. 7 T
MRI will be able to add to our knowledge once it allows an anatomic
observation that is closer to the histopathological ﬁndings [102,103].
However, no data regarding progressive damage in epilepsy have yet
resulted from these advances.
With the emerging knowledge about the role of inﬂammation in
epileptogenesis and possibly in the chronicity and progression of
some types of epilepsies such as TLE–HS, researchers have also fo-
cused on neuroimaging techniques that may be able to image inﬂam-
mation, with promising results from PET and MRI studies [104,105].
3. Translational knowledge: epilepsy progression and
clinical decisions
Despite the controversial results of different studies – which may
be mainly the result of the heterogeneity of the patients included –
most current evidence indicates that TLE–HS is a progressive disorder.
In this context, for patients with TLE–HS, refractoriness to AEDs must
be deﬁned early in the treatment, and surgery must be considered as
soon as possible. For this speciﬁc group of individuals, the early control
of seizures may decrease the risk of progressive structural, cognitive,
and behavior damage related to repeated seizures. Even with some con-
tradictory results [106], different studies have conﬁrmed that for TLE–HS,
age at surgery [107,108] and epilepsy duration are important predictors
for long-term surgical outcome [109]. The remaining question is whether
avoiding the seizures will also be able to block the possible progression
related to the intrinsic pathophysiology of this type of epilepsy. In fact,
one study suggested that stopping seizures after surgical treatment may
reverse some of the brain damage in TLE [110], and other studies further
demonstrated that postoperative seizure freedom reverses part of the
metabolic dysfunction of patients with TLE [111,112].
4. Perspectives for future studies
The progressive characteristic of the epilepsies is still controver-
sial. Current knowledge indicates that TLE–HS is a progressive disor-
der. The contradictory data of different studies may be related to
the heterogeneity of individuals included. The natural history of the
many diverse types of epilepsies may be related to the etiology and
initial epileptogenic process but may also be associated with many
distinct individual characteristics concerning genetic background
and exposure to environmental factors.
Therefore, in order to achieve a satisfactory answer about the pro-
gression of epilepsies, studies must evaluate larger series of individ-
uals for longer periods of follow-up. Moreover, it is important to
control the several genetic and environmental factors that may inﬂu-
ence the epilepsy burden and to give the appropriate importance for
each of them. Only with an appropriate multivariate analysis will we
be able to have a better view of what is the weight of each intrinsic
and extrinsic characteristic for individuals with epilepsy.
With the advances in neuroimaging techniques, in vivo and
non-invasive structural and functional studies will help to improve
the understanding of epilepsy progression.
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